{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:28:02Z","timestamp":1787678882921,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4418-0","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T14:05:43Z","timestamp":1567519543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings"],"prefix":"10.1186","volume":"19","author":[{"given":"Alice E.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchana","family":"Niruttan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Rawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7095-7922","authenticated-orcid":false,"given":"Luke S. P.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"issue":"6","key":"4418_CR1","first-page":"579","volume":"161","author":"RW Snyder","year":"1994","unstructured":"Snyder RW, Glasser DB. Antibiotic therapy for ocular infection. West J Med. 1994;161(6):579\u201384.","journal-title":"West J Med"},{"issue":"6","key":"4418_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/fampra\/19.6.658","volume":"19","author":"H Everitt","year":"2002","unstructured":"Everitt H, Little P. How do GPs diagnose and manage acute infective conjunctivitis? A GP survey. Fam Pract. 2002;19(6):658\u201360.","journal-title":"Fam Pract"},{"key":"4418_CR3","unstructured":"Antimicrobial resistance: global report on surveillance [Internet]. World Health Organisation. 2014 [cited 2018 Jan 17]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/112642\/1\/9789241564748_eng.pdf?ua=1 ."},{"key":"4418_CR4","doi-asserted-by":"crossref","first-page":"e000006","DOI":"10.1136\/bmjophth-2016-000006","volume":"1","author":"A Silvester","year":"2016","unstructured":"Silvester A, Neal T, Czanner G, Briggs M, Harding S, Kaye S. Adult bacterial conjunctivitis: resistance patterns over 12 years in patients attending a large primary eye care Centre in the UK. BMJ Open Ophthalmol. 2016;1:e000006.","journal-title":"BMJ Open Ophthalmol"},{"issue":"4","key":"4418_CR5","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jac\/dku500","volume":"70","author":"R Freeman","year":"2014","unstructured":"Freeman R, Moore LSP, Charlett A, Donaldson H, Holmes AH. Exploring the epidemiology of carbapenem-resistant gram-negative bacteria in West London and the utility of routinely collected hospital microbiology data. J Antimicrob Chemother. 2014;70(4):1212\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"4418_CR6","first-page":"CD001211","volume":"9","author":"A Sheikh","year":"2012","unstructured":"Sheikh A, Hurwitz B, Cp VS, Mclean S, Nurmatov U, Sheikh A, et al. Antibiotics versus placebo for acute bacterial conjunctivitis (review). Cochrane Database Syst Rev. 2012;9:CD001211.","journal-title":"Cochrane Database Syst Rev"},{"key":"4418_CR7","unstructured":"Adult and Children Treatment of Eye Infections and Ophthalmology Handbook. Imperial College Healthcare NHS Trust. Last updated September 2017."},{"key":"4418_CR8","doi-asserted-by":"crossref","unstructured":"Fayers T, Loh GK, Cordeiro MF, Lee V, Jain R, Fayers PM. Overprescribing of antibiotics by UK ophthalmologists. Eye. 2017:1\u20133.","DOI":"10.1038\/eye.2017.191"},{"issue":"11","key":"4418_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4065\/mcp.2011.0358","volume":"86","author":"S Doron","year":"2011","unstructured":"Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc. 2011;86(11):1113\u201323.","journal-title":"Mayo Clin Proc"},{"key":"4418_CR10","unstructured":"Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use [Internet]. National Institute for Health and Care Excellence. 2015 [cited 2018 Jan 17]. p. 1\u201334. Available from: https:\/\/www.nice.org.uk\/guidance\/ng15\/resources\/antimicrobial-stewardship-systems-and-processes-for-effective-antimicrobial-medicine-use-1837273110469"},{"key":"4418_CR11","unstructured":"Public Health England. Summary of antimicrobial prescribing guidance \u2013 managing common infections. PHE publications gateway number: 2018511. Published August 2010. Last updated October 2018. Available from: https:\/\/www.gov.uk\/government\/publications\/managing-common-infections-guidance-for-primary-care ."},{"key":"4418_CR12","unstructured":"BSAC methods for antimicrobial susceptibility testing [internet]. Vol. version 12, BSAC. 2013 [cited 2018 Jan 17]. Available from: http:\/\/bsac.org.uk\/wp-content\/uploads\/2012\/02\/Version-12-Apr-2013_final.pdf ."},{"key":"4418_CR13","unstructured":"UK Standards for Microbiology Investigations: Investigation of Bacterial Eye Infections [Internet]. Public Health England. [cited 2017 Jan 17]. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/612529\/B_2i6.1.pdf"},{"issue":"6","key":"4418_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jmii.2012.08.007","volume":"46","author":"FL Chen","year":"2013","unstructured":"Chen FL, Wang GC, Teng SO, Ou TY, Yu FL, Lee W. Sen. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. J Microbiol Immunol Infect. 2013;46(6):425\u201332.","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"4418_CR15","first-page":"1","volume":"19","author":"R Leclercq","year":"2011","unstructured":"Leclercq R, Cant\u00f3n R, Brown DFJ, Giske CG, Heisig P. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2011;19(2):1\u201334.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"4418_CR16","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.ophtha.2011.04.021","volume":"118","author":"Z Shalchi","year":"2011","unstructured":"Shalchi Z, Gurbaxani A, Baker M, Nash J. Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom. Ophthalmology. 2011;118(11):2161\u20135.","journal-title":"Ophthalmology."},{"issue":"2","key":"4418_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1574-6968.2012.02621.x","volume":"334","author":"J Shankar","year":"2012","unstructured":"Shankar J, Sueke H, Wiehlmann L, Horsburgh MJ, Tuft S, Neal TJ, et al. Genotypic analysis of UK keratitis-associated Pseudomonas aeruginosa suggests adaptation to environmental water as a key component in the development of eye infections. FEMS Microbiol Lett. 2012;334(2):79\u201386.","journal-title":"FEMS Microbiol Lett"},{"issue":"4","key":"4418_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1888-4296(11)70053-X","volume":"4","author":"Mark Eltis","year":"2011","unstructured":"Eltis M. Contact-lens-related microbial keratitis: case report and review. J Opt. 2011;4:122\u20137.","journal-title":"Journal of Optometry"},{"issue":"8","key":"4418_CR19","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bjophthalmol-2013-304486","volume":"98","author":"JC Park","year":"2014","unstructured":"Park JC, Ramasamy B, Shaw S, Ling RHL, Prasad S. A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: clinical presentation, microbiology, management and outcome. Br J Ophthalmol. 2014;98(8):1080\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"4418_CR20","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00417-014-2658-7","volume":"252","author":"A Gupta","year":"2014","unstructured":"Gupta A, Orlans HO, Hornby SJ, Bowler ICJW. Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK. Graefes Arch Clin Exp Ophthalmol. 2014;252(11):1825\u201330.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4418_CR21","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1136\/bjophthalmol-2014-306372","volume":"99","author":"K Weston","year":"2015","unstructured":"Weston K, Nicholson R, Bunce C, Yang YF. An 8-year retrospective study of cataract surgery and postoperative endophthalmitis: injectable intraocular lenses may reduce the incidence of postoperative endophthalmitis. Br J Ophthalmol. 2015;99:1377\u201380.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"4418_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0039-6257(03)00054-7","volume":"48","author":"Timothy L Jackson","year":"2003","unstructured":"Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48:403\u201323.","journal-title":"Survey of Ophthalmology"},{"issue":"11","key":"4418_CR23","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/eye.2016.155","volume":"30","author":"A Maudgil","year":"2016","unstructured":"Maudgil A, Johnson Z, Rogers N, Mudhar HS. Unusual ocular presentations of ocular phaeohyphomycosis. Eye. 2016;30(11):1517\u20139.","journal-title":"Eye."},{"issue":"9","key":"4418_CR24","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/bjophthalmol-2013-304735","volume":"98","author":"PW Flavahan","year":"2014","unstructured":"Flavahan PW, Cauchi P, Gregory ME, Foot B, Drummond SR. Incidence of periorbital necrotising fasciitis in the UK population: a BOSU study. Br J Ophthalmol. 2014;98(9):1177\u201380.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"4418_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","volume":"37","author":"DM Livermore","year":"2011","unstructured":"Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents. 2011;37(5):415\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"16","key":"4418_CR26","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/jama.2013.280318","volume":"310","author":"AA Azari","year":"2013","unstructured":"Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721\u20139.","journal-title":"JAMA."},{"issue":"7148","key":"4418_CR27","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1136\/bmj.316.7148.1903","volume":"316","author":"M Doona","year":"1998","unstructured":"Doona M, Walsh J. Topical chloramphenicol is an outmoded treatment. BMJ. 1998;316(7148):1903.","journal-title":"BMJ."},{"issue":"1","key":"4418_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00417-010-1426-6","volume":"249","author":"A Adebayo","year":"2011","unstructured":"Adebayo A, Parikh JG, McCormick SA, Shah MK, Huerto RS, Yu G, et al. Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the new York eye and ear Infirmary. Graefes Arch Clin Exp Ophthalmol. 2011;249(1):111\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"4418_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2165\/11589020-000000000-00000","volume":"31","author":"Jose Benitez-del-Castillo","year":"2011","unstructured":"Benitez-Del-Castillo J, Verboven Y, Stroman D, Kodjikian L. The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis. Clinical Drug Investigation. 2011;31:543\u201357.","journal-title":"Clinical Drug Investigation"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4418-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4418-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4418-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:19:32Z","timestamp":1721686772000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4418-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4418"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4418-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"15 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data was collected as a routine part of clinical care. The authors did not have not use nor access to any information that enabled them to identify individual patients. Analysis of this data was undertaken as part of a research database approved by Chelsea Research Ethics Committee (ref 18\/ LO\/ 0746).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No patient identifiable data necessitating consent was used in this study. No organisational consent to publish is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LSPM has consulted for bioMerieux (2013), DNAelectronics (2015\u20132018), Dairy Crest (2017\u20132018), received speaker fees from Profile Pharma (2018) and Pfizer (2018\u20132019), received research grants from the National Institute for Health Research (2013\u20132018), Leo Pharma (2016), and CW+ Charity (2017\u20132019), and received educational support from Eumedica (2016\u20132017). All other authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"768"}}